MEDTRN — Meditrina Cyprus Balance Sheet
0.000.00%
- €4.50m
- €4.81m
- €14.95m
- 44
- 96
- 46
- 70
Annual balance sheet for Meditrina Cyprus, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.281 | 0.44 | 0.338 |
Net Total Accounts Receivable | |||
Net Total Receivables | 4.42 | 4.11 | 5.71 |
Total Inventory | |||
Total Current Assets | 6.46 | 7.74 | 8.45 |
Net Property, Plant And Equipment | 0.028 | 0.032 | 0.022 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Total Assets | 15.6 | 17.2 | 17.9 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 6.29 | 8.57 | 8.83 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 9.46 | 11.5 | 11.6 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 6.19 | 5.77 | 6.33 |
Total Liabilities & Shareholders' Equity | 15.6 | 17.2 | 17.9 |
Total Common Shares Outstanding |